The Presence of Modifiable Residues in the Core Peptide Part of Precursor Nisin Is Not Crucial for Precursor Nisin Interactions with NisB- and NisC

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Khusainov, Rustem ^a   Kuipers, Oscar P ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b KLUYVER CENTRE FOR GENOMICS OF INDUSTRIAL FERMENTATION   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; ENZYME; NISB; NISC; NISIN; SERINE; THREONINE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME BINDING; ENZYME MODIFICATION; ENZYME PURIFICATION; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; NONHUMAN; PROTEIN PROTEIN INTERACTION;

ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; CLONING, MOLECULAR; CYSTEINE; GENETIC VARIATION; INTRAMOLECULAR LYASES; LACTOCOCCUS LACTIS; MEMBRANE PROTEINS; NISIN; PEPTIDES; PLASMIDS; PROTEIN BINDING; PROTEIN ENGINEERING; PROTEIN STRUCTURE, TERTIARY; RECOMBINATION, GENETIC; SERINE; SUBSTRATE SPECIFICITY; THREONINE;

EID: 84883634798     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074890     Document Type: Article

References (37)

1. Rayman MK, Aris B, Hurst A, (1981) Nisin: A possible alternative or adjunct to nitrite in the preservation of meats. Appl Environ Microbiol 41: 375-380.
2. Bierbaum G, Szekat C, Josten M, Heidrich C, Kempter C, et al. (1996) Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5. Appl Environ Microbiol 62: 385-392.
3. Siezen RJ, Kuipers OP, de Vos WM, (1996) Comparison of lantibiotic gene clusters and encoded proteins. Antonie Van Leeuwenhoek 69: 171-184.
4. Lubelski J, Rink R, Khusainov R, Moll GN, Kuipers OP, (2008) Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin. Cell Mol Life Sci 65: 455-476.
5. Khusainov R, Heils R, Lubelski J, Moll GN, Kuipers OP, (2011) Determining sites of interaction between prenisin and its modification enzymes NisB and NisC. Mol Microbiol 82: 706-718.
6. Lubelski J, Khusainov R, Kuipers OP, (2009) Directionality and coordination of dehydration and ring formation during biosynthesis of the lantibiotic nisin. J Biol Chem 284: 25962-72.
7. Lee MV, Ihnken LAF, You YO, McClerren AL, van der Donk WA, et al. (2009) Distributive and directional behavior of lantibiotic synthetases revealed by high-resolution tandem mass spectrometry. J Am Chem Soc 131: 12258-12264.
8. Kuipers A, Meijer-Wierenga J, Rink R, Kluskens LD, Moll GN, (2008) Mechanistic dissection of the enzyme complexes involved in biosynthesis of lacticin 3147 and nisin. Appl Environ Microbiol 74: 6591-6597.
9. Krawczyk B, Ensle P, Muller WM, Sussmuth RD, (2012) Deuterium labeled peptides give insights into the directionality of class III lantibiotic synthetase LabKC J Am Chem Soc. 134: 9922-9925.
10. Breukink E, de Kruijff B, (2006) Lipid II as a target for antibiotics. Nat.Rev.Drug Discov. 5: 321-332.
11. Hasper HE, Kramer NE, Smith JL, Hillman JD, Zachariah C, et al. (2006) An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science 313: 1636-1637.
12. Hsu ST, Breukink E, de Kruijff B, Kaptein R, Bonvin AM, et al. (2002) Mapping the targeted membrane pore formation mechanism by solution NMR: The nisin Z and lipid II interaction in SDS micelles. Biochemistry 41: 7670-7676.
13. Hsu ST, Breukink E, Tischenko E, Lutters MA, de Kruijff B, et al. (2004) The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat Struct Mol Biol 11: 963-967.
14. Gut IM, Blanke SR, van der Donk WA, (2011) Mechanism of inhibition of bacillus anthracis spore outgrowth by the lantibiotic nisin. ACS Chem Biol 6: 744-752.
15. Kuipers A, de Boef E, Rink R, Fekken S, Kluskens LD, et al. (2004) NisT, the transporter of the lantibiotic nisin, can transport fully modified, dehydrated, and unmodified prenisin and fusions of the leader peptide with non-lantibiotic peptides. J Biol Chem 279: 22176-22182.
16. Kluskens LD, Kuipers A, Rink R, de Boef E, Fekken S, et al. (2005) Post-translational modification of therapeutic peptides by NisB, the dehydratase of the lantibiotic nisin. Biochemistry 44 (38): 12827-12834.
17. Chatterjee C, Patton GC, Cooper L, Paul M, van der Donk WA, (2006) Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase. Chem Biol 13, Issue 10: 1109-1117.
18. Zhang X, van der Donk WA, (2007) On the substrate specificity of dehydration by lacticin 481 synthetase. J Am Chem Soc 129 (8): 2212-2213.
19. Rink R, Kluskens LD, Kuipers A, Driessen AJM, Kuipers OP, et al. (2007) NisC, the cyclase of the lantibiotic nisin, can catalyze cyclization of designed nonlantibiotic peptides. Biochemistry 46: 13179-13189.
20. Levengood MR, Patton GC, van der Donk WA, (2007) The leader peptide is not required for post-translational modification by lacticin 481 synthetase. J Am Chem Soc 129 (34): 10314-10315.
21. Majchrzykiewicz JA, Lubelski J, Moll GN, Kuipers A, Bijlsma JJE, et al. (2010) Production of a class II two-component lantibiotic of streptococcus pneumoniae using the class I nisin synthetic machinery and leader sequence. Antimicrob Agents Chemother 54: 1498-1505.
22. Khusainov R, Kuipers OP, (2012) When the leader gets loose: In vivo biosynthesis of a leaderless prenisin is stimulated by a trans-acting leader peptide. ChemBioChem 13: 2433-2438.
23. Khusainov R, Moll GN, Kuipers OP, (2013) Identification of distinct nisin leader peptide regions that determine interactions with the modification enzymes NisB and NisC. FEBS Open Bio 3: 237-242.
24. Plat A, Kluskens LD, Kuipers A, Rink R, Moll GN, (2011) Requirements of the engineered leader peptide of nisin for inducing modification, export, and cleavage. Appl Environ Microbiol 77: 604-611.
25. Plat A, Kuipers A, Rink R, Moll GN, (2013) Mechanistic aspects of lanthipeptide leaders. Curr Protein Pept Sci 14: 85-96.
26. Field D, Connor PM, Cotter PD, Hill C, Ross RP, (2008) The generation of nisin variants with enhanced activity against specific gram-positive pathogens. Mol Microbiol 69: 218-230.
27. Molloy EM, Field D, O'Connor PM, Cotter PD, Hill C, et al. (2013) Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity PLoS One. 8: e58530.
28. Chan WC, Leyland M, Clark J, Dodd HM, Lian LY, et al. (1996) Structure-activity relationships in the peptide antibiotic nisin: Antibacterial activity of fragments of nisin. FEBS Lett 390: 129-132.
29. Rink R, Wierenga J, Kuipers A, Kluskens LD, Driessen AJ, et al. (2007) Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-terminal truncation. Appl Environ Microbiol 73: 5809-5816.
30. Kuipers OP, Bierbaum G, Ottenwalder B, Dodd HM, Horn N, et al. (1996) Protein engineering of lantibiotics. Antonie Van Leeuwenhoek 69: 161-169.
31. van Kraaij C, Breukink E, Rollema HS, Bongers RS, Kosters HA, et al. (2000) Engineering a disulfide bond and free thiols in the lantibiotic nisin Z. Eur J Biochem 267: 901-909.
32. Rink R, Kuipers A, de Boef E, Leenhouts KJ, Driessen AJ, et al. (2005) Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes. Biochemistry 44: 8873-8882.
33. Sambrook J, Russell DW (2001) Molecular cloning: A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
34. de Ruyter PG, Kuipers OP, de Vos WM, (1996) Controlled gene expression systems for lactococcus lactis with the food-grade inducer nisin. Appl Environ Microbiol 62: 3662-3667.
35. Breukink E, van Kraaij C, Demel RA, Siezen RJ, Kuipers OP, et al. (1997) The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane. Biochemistry 36: 6968-6976.
36. Garg N, Salazar-Ocampo LM, van der Donk WA, (2013) In vitro activity of the nisin dehydratase NisB. Proc Natl Acad Sci U S A 110: 7258-7263.
37. Wiedemann I, Breukink E, van Kraaij C, Kuipers OP, Bierbaum G, et al. (2001) Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem 276: 1772-1779.